SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-106310
Filing Date
2021-04-05
Accepted
2021-04-05 16:03:05
Documents
26
Period of Report
2021-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d169236d8k.htm   iXBRL 8-K 41770
2 EX-5.1 d169236dex51.htm EX-5.1 37752
3 EX-99.1 d169236dex991.htm EX-99.1 13362
7 GRAPHIC g169236page014.jpg GRAPHIC 203598
8 GRAPHIC g169236page015.jpg GRAPHIC 409621
9 GRAPHIC g169236page016.jpg GRAPHIC 127125
10 GRAPHIC g169236page017.jpg GRAPHIC 208343
11 GRAPHIC g169236page018.jpg GRAPHIC 193083
12 GRAPHIC g169236page019.jpg GRAPHIC 124911
13 GRAPHIC g169236page020.jpg GRAPHIC 152393
14 GRAPHIC g169236page021.jpg GRAPHIC 167378
15 GRAPHIC g169236page022.jpg GRAPHIC 106221
16 GRAPHIC g169236page023.jpg GRAPHIC 136368
17 GRAPHIC g169236sp148.jpg GRAPHIC 3061
18 GRAPHIC g169236sp149.jpg GRAPHIC 1730
  Complete submission text file 0001193125-21-106310.txt   2755197

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA fstx-20210329.xsd EX-101.SCH 3086
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE fstx-20210329_lab.xml EX-101.LAB 18818
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fstx-20210329_pre.xml EX-101.PRE 11846
19 EXTRACTED XBRL INSTANCE DOCUMENT d169236d8k_htm.xml XML 3626
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37718 | Film No.: 21805313
SIC: 2834 Pharmaceutical Preparations